市場調査レポート

商品コード

1301036

RNA分析市場規模、シェア、動向分析レポート：製品別（キット＆試薬、サービス、機器）、技術別（qPCR、マイクロアレイ、シーケンス）、用途別、最終用途別、セグメント予測、2023年～2030年

RNA Analysis Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services, Instruments), By Technology (qPCR, Microarray, Sequencing), By Application, By End-use And Segment Forecasts, 2023 - 2030

出版日: 2023年06月14日 | 発行: Grand View Research

| ページ情報: 英文 180 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 5,950 931,353円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,087,883円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,400,943円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.53円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

RNA分析市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のRNA分析市場規模は2030年までに202億1,000万米ドルに達し、CAGRは10.86％を記録すると予測されています。

トランスクリプトミクスは、ポストゲノム時代における最先端分野の一つです。この業界における技術的進歩は、ポリアデニル化RNAを捕捉するための生命科学におけるトランスクリプトームシーケンスの応用が増加していることに起因しています。次世代ハイスループットシーケンス技術の拡大に伴い、トランスクリプトームの解析はRNAベースの遺伝子の制御ネットワークの理解を徐々に向上させています。例えば、2021年7月、リトアニアの研究チームは、単一細胞内でmRNAとマイクロRNAを同時に捕捉し、配列決定するための液滴ベースの技術を開発しています。

この調査は、欧州連合（EU）から174,000米ドルのHorizon 2020研究助成金を受けています。さらに、2022年5月、CD Genomics社は、配列依存PCRを排除したNGSベースの手法であるDigital RNA sequencing技術を発表しました。このような取り組みにより、市場の成長は間もなく加速すると予想されます。リボ核酸トランスクリプトーム解析は、研究者が生物における遺伝子の位置や特定の遺伝子の機能パターンを解析することを可能にします。この方法は、発生段階におけるすべての転写産物の変化挙動を評価するのに役立ち、遺伝子の転写構造を特定するために、メッセンジャーリボ核酸、非コードリボ核酸、マイクロリボ核酸を含む転写産物のすべての要素を評価します。

遺伝子と薬剤の相互作用を理解するために膨大な数の遺伝子を分析する必要性が高まっていることから、トランスクリプトミクス技術の探索用途や薬剤開発への応用が強化されると予想されます。例えば、COVID-19患者のトランスクリプトーム・プロファイルは、疾患の予後と管理を調べるために解析されています。さらに、個別化された医薬品に対する需要の増加は、予測期間中の業界の成長を促進すると予想されています。2020年4月、Caris Life Sciences社はMI Transcriptome CDxの市販前承認申請をUSFDAに提出したと発表しました。これは強力な精密医療アッセイであり、重要なコンパニオン診断バイオマーカーを含んでいます。一方、トランスクリプトーム研究におけるデータ管理や効果的なバイオインフォマティクスツールの欠如は、業界における主要な課題の一つです。

ハイスループット技術の進化は、複雑な生物学的プロセスの全体像を把握するための貴重な機会を提供してきました。オミックスデータはかなり利用できるようになったにもかかわらず、生物学的データを臨床的に価値のある知識に変換することは、依然として大きな課題の一つです。それは、現在のデータ処理や統合方法が不十分であるだけでなく、既存の解析アプローチの適用が不適切であるためでもあります。北米は、企業による製薬およびバイオテクノロジー研究への投資の増加により、2021年に最も高い収益を上げる地域と報告されています。アジア太平洋は、低コストの製造サービスにより、2022年から2030年にかけて最も速いCAGRを記録すると予測されています。

RNA分析市場レポートハイライト

リアルタイムPCR（qPCR）は2022年の技術分野で主要な市場シェアを占め、予測期間中もこの傾向は続くと予測されます。
トランスクリプトームシーケンス技術は、シーケンス技術の進歩やNGS技術の受け入れ拡大などの要因により、予測期間中に大きなCAGRを記録すると予測されます。
トランスクリプトーム研究における消耗品の利用率が高いことから、キットおよび試薬セグメントは2022年に最も高い収益シェアを占めました。
感染症・病原体分野は2022年に最大のシェアを占め、予測期間中も同様の動向が予測されます。
感染症の流行が増加していることが、このセグメントの成長を促進する主な要因です。
リボ核酸分析の効率的かつ効果的なプロセスのためにハイスループット技術を活用する機関やセンターが増加しているため、政府機関や学術センターがエンドユーザーセグメントを支配しています。

RNA分析市場：製品の変動分析
機器
- 機器市場、2018～2030年（100万米ドル）
キットと試薬
- キットおよび試薬市場、2018-2030（100万米ドル）
- miRNAとsiRNA
- 逆転写酵素とRT-PCR
- RNAの抽出と精製
- RNA干渉
- その他
サービス
- サービス市場、2018-2030（100万米ドル）

第5章テクノロジービジネス分析

RNA分析市場：技術変動分析
リアルタイムPCR（qPCR）
- リアルタイムPCR（qPCR）市場、2018～2030年（100万米ドル）
マイクロアレイ
- マイクロアレイ市場、2018～2030年（100万米ドル）
シーケンス
- シーケンス市場、2018～2030年（100万米ドル）
その他
- その他のテクノロジー市場、2018-2030（100万米ドル）

第6章用途ビジネス分析

RNA分析市場：用途の変動分析
RNA発現アトラスの構築
- RNA発現アトラスの構築市場、2018～2030年（100万米ドル）
エピジェネティクス
- エピジェネティクス市場、2018年～2030年（100万米ドル）
感染症および病原性
- 感染症および病原性市場、2018～2030年（100万米ドル）
代替RNAスプライシング
- 代替RNAスプライシング市場、2018～2030年（100万米ドル）
RNAの構造と分子動力学
- RNAの構造と分子動力学市場、2018～2030年（100万米ドル）
RNA治療薬の開発と提供
- RNA治療薬の開発と提供市場、2018～2030年（100万米ドル）
その他
- その他の用途市場、2018～2030年（100万米ドル）

第7章最終用途ビジネス分析

政府機関と学術センター
- 政府機関および学術センター市場、2018年～2030年（100万米ドル）
製薬およびバイオテクノロジー企業
- 製薬・バイオテクノロジー企業市場、2018年～2030年（100万米ドル）
病院とクリニック
- 病院・クリニック市場、2018年～2030年（100万米ドル）
受託調査機関（CRO）
- 受託調査機関（CRO）市場、2018年～2030年（100万米ドル）

第8章地域ビジネス分析

地域別RNA分析市場シェア、2022年および2030年
北米
- 北米のRNA分析市場、2018年～2030年（100万米ドル）
- 米国
- カナダ
欧州
- 欧州のRNA分析市場、2018年～2030年（100万米ドル）
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋地域
- アジア太平洋地域のRNA分析市場、2018年～2030年（100万米ドル）
- 日本
- 中国
- インド
- オーストラリア
- タイ
- 韓国
ラテンアメリカ
- ラテンアメリカのRNA分析市場、2018年～2030年（100万米ドル）
- ブラジル
- メキシコ
- アルゼンチン
MEA
- MEAのRNA分析市場、2018年～2030年（100万米ドル）
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

会社の分類
戦略マッピング
企業の市場シェア分析、2022年
企業プロファイル・一覧表
- Agilent Technologies, Inc
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Pacific Bioscience of California, Inc.;
- Affymetrix, Inc.
- Danaher
- Promega

図表

List of Tables

Table 1 List of secondary sources
Table 2 Global RNA analysis market, by product, 2018 - 2030 (USD Million)
Table 3 Global RNA analysis market, by technology, 2018 - 2030 (USD Million)
Table 4 Global RNA analysis market, by application, 2018 - 2030 (USD Million)
Table 5 Global RNA analysis market, by end-use, 2018 - 2030 (USD Million)
Table 6 Global RNA analysis market, by region, 2018 - 2030 (USD Million)
Table 7 North America RNA analysis market by product, 2018 - 2030 (USD Million)
Table 8 North America RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 9 North America RNA analysis market by application, 2018 - 2030 (USD Million)
Table 10 North America RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 11 U.S. RNA analysis market by product, 2018 - 2030 (USD Million)
Table 12 U.S. RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 13 U.S. RNA analysis market by application, 2018 - 2030 (USD Million)
Table 14 U.S. RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 15 Canada RNA analysis market by product, 2018 - 2030 (USD Million)
Table 16 Canada RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 17 Canada RNA analysis market by application, 2018 - 2030 (USD Million)
Table 18 Canada RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 19 Europe RNA analysis market by product, 2018 - 2030 (USD Million)
Table 20 Europe RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 21 Europe RNA analysis market by application, 2018 - 2030 (USD Million)
Table 22 Europe RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 23 Germany RNA analysis market by product, 2018 - 2030 (USD Million)
Table 24 Germany RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 25 Germany RNA analysis market by application, 2018 - 2030 (USD Million)
Table 26 Germany RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 27 U.K. RNA analysis market by product, 2018 - 2030 (USD Million)
Table 28 U.K. RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 29 U.K. RNA analysis market by application, 2018 - 2030 (USD Million)
Table 30 U.K. RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 31 France RNA analysis market by product, 2018 - 2030 (USD Million)
Table 32 France RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 33 France RNA analysis market by application, 2018 - 2030 (USD Million)
Table 34 France RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 35 Italy RNA analysis market by product, 2018 - 2030 (USD Million)
Table 36 Italy RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 37 Italy RNA analysis market by application, 2018 - 2030 (USD Million)
Table 38 Italy RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 39 Spain RNA analysis market by product, 2018 - 2030 (USD Million)
Table 40 Spain RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 41 Spain RNA analysis market by application, 2018 - 2030 (USD Million)
Table 42 Spain RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 43 Denmark RNA analysis market by product, 2018 - 2030 (USD Million)
Table 44 Denmark RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 45 Denmark RNA analysis market by application, 2018 - 2030 (USD Million)
Table 46 Denmark RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 47 Sweden RNA analysis market by product, 2018 - 2030 (USD Million)
Table 48 Sweden RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 49 Sweden RNA analysis market by application, 2018 - 2030 (USD Million)
Table 50 Sweden RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 51 Norway RNA analysis market by product, 2018 - 2030 (USD Million)
Table 52 Norway RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 53 Norway RNA analysis market by application, 2018 - 2030 (USD Million)
Table 54 Norway RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 55 Asia Pacific RNA analysis market by product, 2018 - 2030 (USD Million)
Table 56 Asia Pacific RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 57 Asia Pacific RNA analysis market by application, 2018 - 2030 (USD Million)
Table 58 Asia Pacific RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 59 China RNA analysis market by product, 2018 - 2030 (USD Million)
Table 60 China RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 61 China RNA analysis market by application, 2018 - 2030 (USD Million)
Table 62 China RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 63 Japan RNA analysis market by product, 2018 - 2030 (USD Million)
Table 64 Japan RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 65 Japan RNA analysis market by application, 2018 - 2030 (USD Million)
Table 66 Japan RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 67 India RNA analysis market by product, 2018 - 2030 (USD Million)
Table 68 India RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 69 India RNA analysis market by application, 2018 - 2030 (USD Million)
Table 70 India RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 71 Australia RNA analysis market by product, 2018 - 2030 (USD Million)
Table 72 Australia RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 73 Australia RNA analysis market by application, 2018 - 2030 (USD Million)
Table 74 Australia RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 75 Thailand RNA analysis market by product, 2018 - 2030 (USD Million)
Table 76 Thailand RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 77 Thailand RNA analysis market by application, 2018 - 2030 (USD Million)
Table 78 Thailand RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 79 South Korea RNA analysis market by product, 2018 - 2030 (USD Million)
Table 80 South Korea RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 81 South Korea RNA analysis market by application, 2018 - 2030 (USD Million)
Table 82 South Korea RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 83 Latin America RNA analysis market by product, 2018 - 2030 (USD Million)
Table 84 Latin America RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 85 Latin America RNA analysis market by application, 2018 - 2030 (USD Million)
Table 86 Latin America RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 87 Brazil RNA analysis market by product, 2018 - 2030 (USD Million)
Table 88 Brazil RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 89 Brazil RNA analysis market by application, 2018 - 2030 (USD Million)
Table 90 Brazil RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 91 Mexico RNA analysis market by product, 2018 - 2030 (USD Million)
Table 92 Mexico RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 93 Mexico RNA analysis market by application, 2018 - 2030 (USD Million)
Table 94 Mexico RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 95 Argentina RNA analysis market by product, 2018 - 2030 (USD Million)
Table 96 Argentina RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 97 Argentina RNA analysis market by application, 2018 - 2030 (USD Million)
Table 98 Argentina RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 99 MEA RNA analysis market by product, 2018 - 2030 (USD Million)
Table 100 MEA RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 101 MEA RNA analysis market by application, 2018 - 2030 (USD Million)
Table 102 MEA RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 103 South Africa RNA analysis market by product, 2018 - 2030 (USD Million)
Table 104 South Africa RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 105 South Africa RNA analysis market by application, 2018 - 2030 (USD Million)
Table 106 South Africa RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia RNA analysis market by product, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia RNA analysis market by application, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 111 UAE RNA analysis market by product, 2018 - 2030 (USD Million)
Table 112 UAE RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 113 UAE RNA analysis market by application, 2018 - 2030 (USD Million)
Table 114 UAE RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 115 Kuwait RNA analysis market by product, 2018 - 2030 (USD Million)
Table 116 Kuwait RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 117 Kuwait RNA analysis market by application, 2018 - 2030 (USD Million)
Table 118 Kuwait RNA analysis market by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 RNA analysis market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter's five forces analysis
Fig. 14 RNA analysis market: Products outlook and key takeaways
Fig. 15 RNA analysis market: Product movement analysis
Fig. 16 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 miRNA and siRNA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Reverse transcriptase & RT-PCR market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 RNA extraction & purification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 RNA interference market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Others kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 RNA analysis market: Technology outlook and key takeaways
Fig. 25 RNA analysis market: Technology movement analysis
Fig. 26 Real time-PCR (qPCR) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 RNA analysis market: Application outlook and key takeaways
Fig. 31 RNA analysis Market: Application movement analysis
Fig. 32 Construction of RNA expression atlas market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Epigenetics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Infectious diseases and pathogenesis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Alternative RNA splicing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 RNA structure and molecular dynamics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Development and delivery of RNA therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Others applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 RNA analysis market: End-use outlook and key takeaways
Fig. 40 RNA analysis market: End-use movement analysis
Fig. 41 Government institutes & academic centers estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Pharmaceutical & biotechnology companies estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Hospitals & clinics estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Contract Research Organizations (CROs) estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 RNA analysis market: Regional outlook and key takeaways
Fig. 46 RNA analysis market: Regional movement analysis
Fig. 47 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Norway market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Product Code: 978-1-68038-534-2

RNA Analysis Market Growth & Trends

The global RNA analysis market size is expected to reach USD 20.21 billion by 2030, registering a CAGR of 10.86% according to a new report by Grand View Research, Inc.. Transcriptomics is one of the most advanced fields in the post-genomic period. Technological advancements in this industry can be attributed to the increasing applications of transcriptome sequencing in life science for capturing polyadenylated RNA. With the expansion of next-generation high-throughput sequencing technology, the analysis of transcriptomes has been gradually improving the understanding of the regulatory network of RNA-based genes. For instance, in July 2021, the Lithuanian team is developing a droplet-based technique for simultaneous mRNA and microRNA capture and sequencing in a single cell.

The research is backed by the European Union with a USD174,000 Horizon 2020 research grant. Moreover, in May 2022, CD Genomics launched the Digital RNA sequencing technology, which is an NGS-based method that excludes sequence-dependent PCR. Such initiatives are anticipated to accelerate market growth shortly. Ribonucleic acid transcriptome analysis enables the researchers to analyze the position of genes as well as the functional patterns of a specific gene in an organism. The method assists in evaluating every transcript's changing behavior at the development stage and assesses all the elements of a transcript, including messenger ribonucleic acid, non-coding ribonucleic acid, and micro ribonucleic acid, for identifying the transcriptional structure of genes.

The growing need for analyzing a huge number of genes to understand the gene-to-drug interactions is anticipated to enhance the application of transcriptomics technologies in discovery applications and drug development. For instance, transcriptome profiles of COVID-19 patients have been analyzed to examine the disease prognosis and management. Furthermore, increasing demand for personalized medicines is anticipated to fuel the industry growth during the forecast period. In April 2020, Caris Life Sciences announced the submission of Pre-Market Approval applications for MI Transcriptome CDx to the USFDA. It is a powerful precision medicine assay, which contains significant companion diagnostic biomarkers. On the other hand, data management in transcriptomic research and the lack of effective bioinformatics tools are some of the major challenges in the industry.

The evolution of high-throughput technologies has provided invaluable opportunities for generating holistic views of complex biological processes. Despite the considerable availability of omics data, the conversation of biological data into clinically valuable knowledge remains one of the major challenges. It is not only because of insufficient current data processing or integration methods but also for inappropriate application of existing analysis approaches. North America has been reported as the highest revenue-generating region in 2021 owing to increasing investments in pharmaceutical and biotechnology research by corporations. Asia Pacific is projected to register the fastest CAGR from 2022 to 2030 owing to the low-cost manufacturing services.

RNA Analysis Market Report Highlights

Real-Time- PCR (qPCR) accounted for the major market share in the technology segment in 2022 and is said to continue the trend during the forecast period owing to the increasing use of PCR for COVID-19 diagnostic across the globe
The transcriptome sequencing technology is estimated to register a significant CAGR during the forecast period owing to factors, such as advancements in sequencing technology and growing acceptance of NGS technology
The kits and reagents segment accounted for the highest revenue share in 2022 owing to a high utilization rate of consumables during transcriptomic studies
The infectious diseases and pathogenesis segment accounted for the largest share in 2022 and is anticipated to have a similar trend during the forecasted period
The increasing prevalence of the infectious disease is the major factor driving the segment growth
Government institutes & academic centers dominated the end-user segment as the increasing number of institutes and centers leveraged high throughput technologies for the effective and efficient process of ribonucleic acid analysis

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Information Analysis
- 1.2.2. Market Formulation & Data Visualization
- 1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
- 1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
- 1.9.1. Objective 1:
- 1.9.2. Objective 2:

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing Demand for Transcriptomics in Cancer Personalized/Precision Medicine
  - 3.2.1.2. Rising Diagnostic Utility Of Transcriptomics Technologies
  - 3.2.1.3. Advent of Novel Approaches for Understanding Gene Expression at RNA Level
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Higher Cost of Research & Developments
  - 3.2.2.2. High Costs Associated With Analysis Platforms
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

4.1. RNA Analysis Market: Product Movement Analysis
4.2. Instruments
- 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.3. Kits & Reagents
- 4.3.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
- 4.3.2. miRNA & siRNA
  - 4.3.2.1. miRNA & siRNA Market, 2018 - 2030 (USD Million)
- 4.3.3. Reverse Transcriptases & RT-PCR
  - 4.3.3.1. Reverse Transcriptases & RT-PCR Market, 2018 - 2030 (USD Million)
- 4.3.4. RNA Extraction & Purification
  - 4.3.4.1. RNA Extraction & Purification Market, 2018 - 2030 (USD Million)
- 4.3.5. RNA Interference
  - 4.3.5.1. RNA Interference Market, 2018 - 2030 (USD Million)
- 4.3.6. Others
  - 4.3.6.1. Other Kits & Reagents Market, 2018 - 2030 (USD Million)
4.4. Services
- 4.4.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

5.1. RNA Analysis Market: Technology Movement Analysis
5.2. Real Time-PCR (qPCR)
- 5.2.1. Real Time-PCR (qPCR) Market, 2018 - 2030 (USD Million)
5.3. Microarray
- 5.3.1. Microarray Market, 2018 - 2030 (USD Million)
5.4. Sequencing
- 5.4.1. Sequencing Market, 2018 - 2030 (USD Million)
5.5. Others
- 5.5.1. Other Technologies Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

6.1. RNA Analysis Market: Application Movement Analysis
6.2. Construction of RNA Expression Atlas
- 6.2.1. Construction of RNA Expression Atlas Market, 2018 - 2030 (USD Million)
6.3. Epigenetics
- 6.3.1. Epigenetics Market, 2018 - 2030 (USD Million)
6.4. Infectious Diseases & Pathogenesis
- 6.4.1. Infectious Diseases & Pathogenesis Market, 2018 - 2030 (USD Million)
6.5. Alternative RNA Splicing
- 6.5.1. Alternative RNA Splicing Market, 2018 - 2030 (USD Million)
6.6. RNA Structure & Molecular Dynamics
- 6.6.1. RNA Structure & Molecular Dynamics Market, 2018 - 2030 (USD Million)
6.7. Development & Delivery of RNA Therapeutics
- 6.7.1. Development & Delivery of RNA Therapeutics Market, 2018 - 2030 (USD Million)
6.8. Others
- 6.8.1. Other Applications Market, 2018 - 2030 (USD Million)

Chapter 7. End-Use Business Analysis

7.1. Government Institutes & Academic Centers
- 7.1.1. Government Institutes & Academic Centers Market, 2018 - 2030 (USD Million)
7.2. Pharmaceutical & Biotechnology Companies
- 7.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
7.3. Hospitals & Clinics
- 7.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
7.4. Contract Research Organizations (CROs)
- 7.4.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

8.1. RNA Analysis Market Share By Region, 2022 & 2030
8.2. North America
- 8.2.1. North America RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
  - 8.2.2.1. Key Country Dynamics
  - 8.2.2.2. Target Disease Prevalence
  - 8.2.2.3. Competitive Scenario
  - 8.2.2.4. U.S. RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.2.3. Canada
  - 8.2.3.1. Key Country Dynamics
  - 8.2.3.2. Target Disease Prevalence
  - 8.2.3.3. Competitive Scenario
  - 8.2.3.4. Canada RNA Analysis Market, 2018 - 2030 (USD Million)
8.3. Europe
- 8.3.1. Europe RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.3.2. UK
  - 8.3.2.1. Key Country Dynamics
  - 8.3.2.2. Target Disease Prevalence
  - 8.3.2.3. Competitive Scenario
  - 8.3.2.4. UK RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.3.3. Germany
  - 8.3.3.1. Key Country Dynamics
  - 8.3.3.2. Target Disease Prevalence
  - 8.3.3.3. Competitive Scenario
  - 8.3.3.4. Germany RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.3.4. France
  - 8.3.4.1. Key Country Dynamics
  - 8.3.4.2. Target Disease Prevalence
  - 8.3.4.3. Competitive Scenario
  - 8.3.4.4. France RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.3.5. Italy
  - 8.3.5.1. Key Country Dynamics
  - 8.3.5.2. Target Disease Prevalence
  - 8.3.5.3. Competitive Scenario
  - 8.3.5.4. Italy RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.3.6. Spain
  - 8.3.6.1. Key Country Dynamics
  - 8.3.6.2. Target Disease Prevalence
  - 8.3.6.3. Competitive Scenario
  - 8.3.6.4. Spain RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.3.7. Denmark
  - 8.3.7.1. Key Country Dynamics
  - 8.3.7.2. Target Disease Prevalence
  - 8.3.7.3. Competitive Scenario
  - 8.3.7.4. Denmark RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.3.8. Sweden
  - 8.3.8.1. Key Country Dynamics
  - 8.3.8.2. Target Disease Prevalence
  - 8.3.8.3. Competitive Scenario
  - 8.3.8.4. Sweden RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.3.9. Norway
  - 8.3.9.1. Key Country Dynamics
  - 8.3.9.2. Target Disease Prevalence
  - 8.3.9.3. Competitive Scenario
  - 8.3.9.4. Norway RNA Analysis Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
- 8.4.1. Asia Pacific RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.4.2. Japan
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Target Disease Prevalence
  - 8.4.2.3. Competitive Scenario
  - 8.4.2.4. Japan RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.4.3. China
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Target Disease Prevalence
  - 8.4.3.3. Competitive Scenario
  - 8.4.3.4. China RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.4.4. India
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Target Disease Prevalence
  - 8.4.4.3. Competitive Scenario
  - 8.4.4.4. India RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.4.5. Australia
  - 8.4.5.1. Key Country Dynamics
  - 8.4.5.2. Target Disease Prevalence
  - 8.4.5.3. Competitive Scenario
  - 8.4.5.4. Australia RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.4.6. Thailand
  - 8.4.6.1. Key Country Dynamics
  - 8.4.6.2. Target Disease Prevalence
  - 8.4.6.3. Competitive Scenario
  - 8.4.6.4. Thailand RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.4.7. South Korea
  - 8.4.7.1. Key Country Dynamics
  - 8.4.7.2. Target Disease Prevalence
  - 8.4.7.3. Competitive Scenario
  - 8.4.7.4. South Korea RNA Analysis Market, 2018 - 2030 (USD Million)
8.5. Latin America
- 8.5.1. Latin America RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Target Disease Prevalence
  - 8.5.2.3. Competitive Scenario
  - 8.5.2.4. Brazil RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.5.3. Mexico
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Target Disease Prevalence
  - 8.5.3.3. Competitive Scenario
  - 8.5.3.4. Mexico RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.5.4. Argentina
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Target Disease Prevalence
  - 8.5.4.3. Competitive Scenario
  - 8.5.4.4. Argentina RNA Analysis Market, 2018 - 2030 (USD Million)
8.6. MEA
- 8.6.1. MEA RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.6.2. South Africa
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Target Disease Prevalence
  - 8.6.2.3. Competitive Scenario
  - 8.6.2.4. South Africa RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.6.3. Saudi Arabia
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Target Disease Prevalence
  - 8.6.3.3. Competitive Scenario
  - 8.6.3.4. Saudi Arabia RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.6.4. UAE
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Target Disease Prevalence
  - 8.6.4.3. Competitive Scenario
  - 8.6.4.4. UAE RNA Analysis Market, 2018 - 2030 (USD Million)
- 8.6.5. Kuwait
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Target Disease Prevalence
  - 8.6.5.3. Competitive Scenario
  - 8.6.5.4. Kuwait RNA Analysis Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
- 9.4.1. Agilent Technologies, Inc
  - 9.4.1.1. Overview
  - 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Strategic Initiatives
- 9.4.2. F. Hoffmann-La Roche AG
  - 9.4.2.1. Overview
  - 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Strategic Initiatives
- 9.4.3. Illumina, Inc.
  - 9.4.3.1. Overview
  - 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Strategic Initiatives
- 9.4.4. QIAGEN
  - 9.4.4.1. Overview
  - 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Strategic Initiatives
- 9.4.5. Thermo Fisher Scientific, Inc.
  - 9.4.5.1. Overview
  - 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Strategic Initiatives
- 9.4.6. Eurofins Scientific
  - 9.4.6.1. Overview
  - 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Strategic Initiatives
- 9.4.7. Merck KGaA
  - 9.4.7.1. Overview
  - 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Strategic Initiatives
- 9.4.8. Bio-Rad Laboratories, Inc.
  - 9.4.8.1. Overview
  - 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Strategic Initiatives
- 9.4.9. Pacific Bioscience of California, Inc.;
  - 9.4.9.1. Overview
  - 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Strategic Initiatives
- 9.4.10. Affymetrix, Inc.
  - 9.4.10.1. Overview
  - 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Strategic Initiatives
- 9.4.11. Danaher
  - 9.4.11.1. Overview
  - 9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.11.3. Product Benchmarking
  - 9.4.11.4. Strategic Initiatives
- 9.4.12. Promega
  - 9.4.12.1. Overview
  - 9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.12.3. Product Benchmarking
  - 9.4.12.4. Strategic Initiatives

RNA分析市場規模、シェア、動向分析レポート：製品別（キット＆試薬、サービス、機器）、技術別（qPCR、マイクロアレイ、シーケンス）、用途別、最終用途別、セグメント予測、2023年～2030年

RNA Analysis Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services, Instruments), By Technology (qPCR, Microarray, Sequencing), By Application, By End-use And Segment Forecasts, 2023 - 2030

RNA分析市場の成長と動向

RNA分析市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章市場変数、動向、および範囲

第4章製品ビジネス分析

第5章テクノロジービジネス分析

第6章用途ビジネス分析

第7章最終用途ビジネス分析

第8章地域ビジネス分析

第9章競合情勢

List of Tables

List of Figures

RNA Analysis Market Growth & Trends

RNA Analysis Market Report Highlights

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Product Business Analysis

Chapter 5. Technology Business Analysis

Chapter 6. Application Business Analysis

Chapter 7. End-Use Business Analysis

Chapter 8. Regional Business Analysis

Chapter 9. Competitive Landscape

RNA分析市場規模、シェア、動向分析レポート：製品別（キット＆試薬、サービス、機器）、技術別（qPCR、マイクロアレイ、シーケンス）、用途別、最終用途別、セグメント予測、2023年～2030年

RNA Analysis Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services, Instruments), By Technology (qPCR, Microarray, Sequencing), By Application, By End-use And Segment Forecasts, 2023 - 2030

RNA分析市場の成長と動向

RNA分析市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

第4章 製品ビジネス分析

第5章 テクノロジービジネス分析

第6章 用途ビジネス分析

第7章 最終用途ビジネス分析

第8章 地域ビジネス分析

第9章 競合情勢

List of Tables

List of Figures

RNA Analysis Market Growth & Trends

RNA Analysis Market Report Highlights

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Product Business Analysis

Chapter 5. Technology Business Analysis

Chapter 6. Application Business Analysis

Chapter 7. End-Use Business Analysis

Chapter 8. Regional Business Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章市場変数、動向、および範囲

第4章製品ビジネス分析

第5章テクノロジービジネス分析

第6章用途ビジネス分析

第7章最終用途ビジネス分析

第8章地域ビジネス分析

第9章競合情勢